Synapse Medicine and Dedalus partner on Medication Reconciliation


Synapse Medicine, the leading Medication Intelligence technology, announces a partnership on medication reconciliation with Dedalus, the leading Electronic Health Record (EHR) provider in Europe.

The medication reconciliation process compares a patient’s medication orders to all of the patient’s medications and aims to avoid errors such as omissions, drug interactions, or dosing errors. Hence, medication reconciliation is essential to preventing medication errors at each transition in care and ensuring patients adhere to their treatment. In France, 47% to 67% of patients present an error or discrepancy between their chronic treatments and those prescribed in the hospital. Moreover, 18% to 59% of these errors are responsible for serious adverse drug events according to the French Ministry of Solidarity and Health.

Synapse Medicine is one of the leading European healthtech startups and partners with top university hospitals to simplify the medication reconciliation process. With this partnership, Its medication reconciliation module will now be the only one natively integrated into Dedalus EHR systems. This partnership is the result of several months of research and development, bringing together the pharmaceutical and technological expertise of both players to improve coordinated care.

Healthcare professionals using the DxCare, Orbis, and Dopasys electronic health records systems will be able to directly access Synapse Medicine’s module. Thus, the patient’s information will be automatically shared between the EHR and Synapse. To get access to it, hospitals  will need to subscribe to Synapse Medicine’s medication reconciliation add-on.

“This partnership makes it even easier to deploy the Synapse platform in healthcare institutions. This is a new step, which brings us closer to our mission: to provide everyone access to the best possible medicine,” said Dr. Clement Goehrs, co-founder and CEO of Synapse Medicine.